Stage Iv Lung Cancer AJCC V8

AUG 13, 2026 · PHASE 1 TRIAL

Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer

ClinicalTrials.gov

Phase 1b dose-escalation trial with no results reported; this is a registry record describing a planned study design, not outcome data.

AUG 12, 2026 · PHASE 2 TRIAL

Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases

ClinicalTrials.gov

This is a Phase 2 trial registry record with only 5 enrolled participants and no results posted; it represents early-phase work that requires confirmation.

AUG 4, 2026 · PHASE 2 TRIAL

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

ClinicalTrials.gov

This is an active Phase 2 trial registration with no results posted; the study design and rationale are described but no efficacy or safety outcomes are reported.